Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum
Launched by HOSPITAL UNIVERSITARI DE BELLVITGE · Jul 18, 2011
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low or middle rectal adenocarcinoma without involvement of the anal sphincter
- • Neoadjuvant chemoradiotherapy
- • Age older than 18 years
- • Wexner index of less than 5
- • Signed informed consent
- Exclusion Criteria:
- • Involvement of the anal sphincter
- • Wexner index of 5 or more
- • Declined informed consent
- • Psychological or social problems
About Hospital Universitari De Bellvitge
Hospital Universitari de Bellvitge is a leading academic medical center located in L'Hospitalet de Llobregat, Spain, affiliated with the University of Barcelona. Renowned for its commitment to advanced patient care, innovative research, and education, the hospital plays a pivotal role in the development and execution of clinical trials across various therapeutic areas. With a multidisciplinary team of healthcare professionals and researchers, Hospital Universitari de Bellvitge strives to enhance medical knowledge and improve treatment outcomes through rigorous scientific inquiry and collaboration. Its state-of-the-art facilities and comprehensive patient care services make it an ideal environment for conducting high-quality clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials